BUSINESSDESK: London-based New Zealand oil and gas explorer Kea Petroleum has announced a commercial oil discovery after flow-testing at its onshore Taranaki Puka-1 well, and is to begin a second well quickly to produce early cashflow.
Listed on the secondary AIM board, Kea says Puka-1 has produced a maximum flow rate of 310 barrels of oil and 1.8 million cubic feet of gas daily, with a testing programme now determining the best production arrangements for future field performance.
Planning for Puka-2 is well advanced and will be a larger-capacity rig to allow higher flow rates and greater production flexibility.
The company's Wingrove production facilities will be moved to the Puka site to allow production from Puka-1 to be started without delay after completion of the main build-up phase of the current test, the company says in a statement lodged with the AIM exchange.
"We are delighted that the latest oil and gas flow and down hole pressures data have led to the conclusion that the Puka discovery is indeed a commercial oil field discovery," chairman Ian Gowrie-Smith says.
Kea would seek to "convert this discovery into a cashflow as soon as possible".
This article is tagged with the following keywords. Find out more about MyNBR Tags
Most listened to
- Paul Brislen discusses the 'snake oil' sales tactics of SalesConcepts
- Fonterra chief executive Theo Spierings reveals his ambitious China plan
- UDC Finance chief executive Wayne Percival talks about the company's profit
- Hamish McNicol discusses the latest court stories
- Trilogy International CEO Angela Buglass reviews another bumper result
- Eroad CEO Steven Newman talks about his company's revenue increase
- What do the latest terrorism attacks in Mali and Israel mean? Nathan Smith discusses the latest foreign affairs news
- NZ Windfarms departing director Michael Stiassny speaks out after board exit
- James Mayo talks about SOS Hydration's growth plans after Snowball offer
- Michael Wood on whether he would run in Mt Roskill
- SAFE's Abi Izzard quizzed over protest of a caged hen operation at Pukekohe
- Nevil Gibson talks about Editor's Insight on the planned $US150 million merger between Pfizer and Allergan